Whole-body F-18 FDG PET for hepatocellular carcinoma patients after interventional treatment

Neoplasma

Volumn 54, Issue 4, 2007, Pages 342-347

  Cheng, M F ^a   Wu, Y W ^a   Tzen, K Y ^a   Huang, Y H ^a   Yen, R F ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

FDG; Hepatocellular carcinoma; Metastases; Positron emission tomography; Recurrence

Indexed keywords

FLUORODEOXYGLUCOSE F 18; ALCOHOL; ALPHA FETOPROTEIN; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; WHOLE BODY PET; BLOOD; CATHETER ABLATION; LIVER TUMOR; METABOLISM; MIDDLE AGED; SCINTISCANNING; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; ETHANOL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

EID: 35448938848     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. EL-SERAG HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002; 35: S72-8.
2. DODD GD 3RD, MILLER WJ, BARON RL, et al. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique. Am J Roentgenol. 1992; 159: 727-733
3. COAKLEY FV, SCHWARTZ LH. Imaging of hepatocellular carcinoma: a practical approach. Semin Oncol. 2001; 28: 460-473 (Pubitemid 32959593)
4. SACCHERI S, LOVARIA A, SANGIOVANNI A, et al. Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas. J Vasc Interv Radiol. 2002; 13: 995-999 (Pubitemid 35231855)
5. TORIZUKA T, TAMAKI N, INOKUMA T, et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med. 1995; 36: 1811-1817
6. KHAN MA, COMBS CS, BRUNT EM, et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol. 2000; 32: 792-797 (Pubitemid 30262739)
7. TROJAN J, SCHROEDER O, RAEDLE J, et al. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol. 1999; 94: 3314-3319
8. 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J Gastroenterol. 2004; 39: 961-968
9. EDMONSON HA, STEINER PE. Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer. 1954; 7: 462-503.
10. KUBOTA K, INA H, OKADA Y, et al. Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography. Dig Dis Sci. 2003; 48: 581-586
11. SHEU JC, SUNG JL, CHEN DS, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology. 1985; 89: 259-266 (Pubitemid 15028580)
12. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med. 2003; 44: 213-221
13. 11C-acetate. a new tracer for the evaluation of hepatocellular carcinoma. J Nucl Med 2003; 44: 222-223
14. SASAKI Y, IMAOKA S, ISHIGURO S, et al. Clinical features of small hepatocellular carcinomas as assessed by histologic grades. Surgery. 1996; 119: 252-260
15. GROBHOLZ R, HACKER HJ, THORENS B, et al. Reduction in the expression of glucose transporter protein GLUT2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT1 in late stages of hepatocarcinogenesis. Cancer Res. 1993; 53: 4204-4211
16. BRAGA FJ, FLAMEN P, MORTELMANS L, et al. Ga-67-positive and F-18 FDG-negative imaging in well-differentiated hepatocellular carcinoma. Clin Nucl Med. 2001; 26: 642.
17. LARCOS G, MAISEY MN. FDG-PET screening for cerebral metastases in patients with suspected malignancy. Nucl Med Commun. 1996; 17: 197-198
18. 18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2004; 31: 1614-1620
19. 18F-FDG PET images obtained 2 hours after intravenous injection in liver tumor. Ann Nucl Med. 2002; 16: 169-176
20. 18F-FDG PET imaging in the detection of hepatocellular carcinoma. Nucl Med Commun. 2005; 26: 31-121